Venkat Reddy
Chief Executive Officer at Macrophage Pharma Ltd.
Profile
Venkat Reddy was the founder of Advanced Proteome Therapeutics, Inc. (founded in 2016) where he served as the Chief Executive Officer from 2016 to 2017.
He currently holds the position of Chief Executive Officer at Macrophage Pharma Ltd.
since 2020, Chief Science Officer at General Inception Management LLC since 2022, and Board Member at Tavira Therapeutics since 2023.
Additionally, he is a Board of Director at Pharmacelera SL starting from 2023.
In his former positions, Dr. Reddy worked as a Senior Director at Pfizer Inc. from 2014 to 2016, Senior Director at Sanofi from 2013 to 2014, and Senior Vice President at Glenmark Pharmaceuticals Ltd.
from 2018 to 2019.
He obtained a doctorate degree from Ludwig-Maximilians-Universität München.
Venkat Reddy active positions
| Companies | Position | Start |
|---|---|---|
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Chief Executive Officer | 2021-05-31 |
Pharmacelera SL
 Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain. | Director/Board Member | 2023-02-28 |
General Inception
 General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | 2022-01-31 |
Former positions of Venkat Reddy
| Companies | Position | End |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 2019-09-30 |
Advanced Proteome Therapeutics, Inc.
 Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a private company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Chief Executive Officer | 2017-04-30 |
| PFIZER, INC. | Director/Board Member | 2016-07-31 |
| SANOFI | Director/Board Member | 2014-05-31 |
Training of Venkat Reddy
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SANOFI | Commercial Services |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Advanced Proteome Therapeutics, Inc.
Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a private company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Health Technology |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Health Technology |
Pharmacelera SL
Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain. | Technology Services |
General Inception
General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Finance |
- Stock Market
- Insiders
- Venkat Reddy